Question 1

What is the catalog number for Recombinant Feline Rhodopsin (RHO)?

Accepted Answer

The catalog number for Recombinant Feline Rhodopsin (RHO) is AP2C177.

Question 2

What sizes are available for Recombinant Feline Rhodopsin (RHO)?

Accepted Answer

Recombinant Feline Rhodopsin (RHO) is available in the following size(s): 1 mg, 100 µg, 20 µg.

Question 3

How many pack sizes does Recombinant Feline Rhodopsin (RHO) come in?

Accepted Answer

Recombinant Feline Rhodopsin (RHO) is available in 3 different pack sizes.

Question 4

Is Recombinant Feline Rhodopsin (RHO) in stock?

Accepted Answer

Recombinant Feline Rhodopsin (RHO) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 6

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Question 7

Can I return this product if I ordered the wrong one?

Accepted Answer

As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.

Recombinant Feline Rhodopsin (RHO)

Product Specifications

Type

Source

Species

Available Sizes

Frequently Asked Questions

Explore Other Products

AREL1 Antibody

AREL1 Antibody

AREL1 Antibody

LRRK2 Human Gene Knockout Kit (CRISPR)

CXCR6 Recombinant Rabbit Monoclonal Antibody [JE66-40]

XKR3 Human Gene Knockout Kit (CRISPR)